Ambry’s CARE for COVID Program™ will help OC residents to make informed decisions about testing, frequency of wellness checks, and health management In a press conference held on November 17, 2020, Vice Chairman Andrew Do of the Orange County Board of Supervisors (BOS), who represents the First ...
The CARE for COVID Program, led by KMPM company Ambry Genetics, helps employers address critical challenges surrounding COVID-19 testing, including helping determine who can return to work, who should be tested, the frequency of employee wellness checks, and test type. (Aliso Viejo, CA) June 29, ...
Aliso Viejo, CA (20 May 2020) – Konica Minolta Precision Medicine, Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the acquisition of the assets of Backpack Health (BPH), a secure mobile and web-based health data management platform. The BPH tool empowers patients ...
The first notable improvement in diagnostic yield for high-risk cancer genes in more than 10 years, +RNAinsight adds RNA genetic testing to DNA multigene panels (Aliso Viejo, CA) February 25, 2020: Ambry Genetics (Ambry), a leading clinical genetic testing lab, announced the publication of a ...
BOSTON, MA, 28 January 2020 – Invicro LLC, a Konica Minolta company announces that the paper “Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1” has been published in Nature Communications. Invicro is a global provider of imaging biomarkers, ...
(BOSTON, MA and NEW YORK, NY) January 14, 2020 — Invicro LLC, a Konica Minolta Company and Paige, Inc., the leader in computational pathology, today announced a strategic alliance to provide integrated pathology solutions to support Pharmaceutical and Biotechnology sponsors with their drug discovery ...
(BOSTON, MA) December 23, 2019 — Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer. Dr. Silva will assume the day-to-day leadership responsibilities of the Company and will join Invicro’s Board of Directors, effective ...
+RNAinsight™ is now available for New York patients, and will help identify thousands more patients at increased risk for cancer (Aliso Viejo, CA) December 16, 2019: Ambry Genetics® (Ambry), a leading clinical genetic testing company, announced today that the New York State Clinical Laboratory ...
Separate data demonstrated that finding mutations that increase risks for breast cancer frequently led clinicians to change their medical recommendations to patients. (Aliso Viejo, CA) December 10, 2019: Researchers at Ambry Genetics (Ambry), a leading clinical genetic testing lab, will announce ...
Partnership combines Caris’ somatic and Ambry’s germline testing strengths to provide clinicians with unique information about the molecular and genetic components of a patient’s cancer IRVING, Texas and ALISO VIEJO, Calif., December 4, 2019 – Caris Life Sciences®, a leading innovator ...